Approval · Notice of Compliance 22760 · 2019
VELTASSA: Notice of Compliance 22760
Issued October 7, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22760
- Date
- October 7, 2019
- Company
- Vifor Fresenius Medical Care Renal Pharma LtdSt Gallen, St Gallen, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Revise the labels including the product monograph package insert and mock up labels to change the importer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELTASSA | Not yet assigned | — |
Medicinal ingredients
- PATIROMER SORBITEX CALCIUM 8.4 G per PCK
- PATIROMER SORBITEX CALCIUM 16.8 G per PCK
- PATIROMER SORBITEX CALCIUM 25.2 G per PCK